Late-onset clozapine-induced neutropenia treated with lithium

dc.authoridGorgulu, Yasemin/0000-0002-3401-4879
dc.authorid, Rugül/0000-0003-2596-0473
dc.authorwosidGorgulu, Yasemin/S-4355-2017
dc.authorwosid, Rugül/AAI-1711-2019
dc.contributor.authorDurmus, Pelin Tas
dc.contributor.authorGorgulu, Yasemin
dc.contributor.authorSonmez, Mehmet Bulent
dc.contributor.authorCinar, Rugul Kose
dc.date.accessioned2024-06-12T10:56:41Z
dc.date.available2024-06-12T10:56:41Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.description.abstractClozapine is a second-generation antipsychotic drug, proven to be effective in treatment-resistant schizophrenia. Among patients using clozapine; the incidence of neutropenia is approximately 3% and the incidence of agranulocytosis is approximately 1%. This side effect is diminishing after 18 weeks of drug initiation. Here, we present a case of clozapine-induced neutropenia in a schizophrenic patient seen after 7 years of clozapine use and its treatment with lithium supplementation.en_US
dc.identifier.doi10.14744/DAJPNS.2019.00011
dc.identifier.endpage77en_US
dc.identifier.issn1018-8681
dc.identifier.issn1309-5749
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85064720930en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage74en_US
dc.identifier.trdizinid323812en_US
dc.identifier.urihttps://doi.org/10.14744/DAJPNS.2019.00011
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/323812
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19886
dc.identifier.volume32en_US
dc.identifier.wosWOS:000462731800011en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherYerkure Tanitim & Yayincilik Hizmetleri A Sen_US
dc.relation.ispartofDusunen Adam-Journal Of Psychiatry And Neurological Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectClozapineen_US
dc.subjectLithiumen_US
dc.subjectNeutropeniaen_US
dc.subjectColony-Stimulating Factoren_US
dc.subjectContinuing Clozapineen_US
dc.subjectRechallengeen_US
dc.subjectAgranulocytosisen_US
dc.subjectLeukopeniaen_US
dc.titleLate-onset clozapine-induced neutropenia treated with lithiumen_US
dc.typeArticleen_US

Dosyalar